COVID KAVACH – MERILISA

ICMR-NIV Anti-SARS CoV-2 Human IgG ELISA COVID KAVACH – MERILISA is an Enzyme immunoassay based on Indirect ELISA Principle for the detection of Covid-19 (SARS CoV-2) IgG antibodies in Human Serum/Plasma. It is intended for qualitative detection of IgG antibodies in serum/plasma of patients presenting clinical signs and symptoms consistent with SARS CoV-2 infection.

Click here to know more about Covid-19 testing solutions

  • Certified protocol by ICMR and Evaluated by ICMR NIV, Pune
  • Based on Indirect ELISA principle
  • Ready to use Enzyme Conjugate and controls
  • Neat Sample volume: 5μl
  • User friendly protocol
  • Breakapart wells

Benefits

Indication

  • Best suited for the determination of previous infection or indicative of adaptive immunity
  • Compatible for SEROLOGICAL SURVEILLANCE STUDIES

Product Specifications

Intended Use IgG antibodies from serum / plasma of human will bind to the SARS CoV-2 virus whole cell antigen coated on to the Microtitre plate (ELISA wells). In the next step, anti Human IgG HRP binds to captured human IgG antibodies.
Subsequently, chromogenic substrate (TMB/H2O2) is added, the reaction is stopped by 1N H2SO4. The intensity of color / optical density is measured at 450 nm. The kit is for in- vitro use for monitoring anti-SARS CoV-2 antibodies
in human only.
Principle Indirect ELISA
Technique Enzyme Linked Immunosorbant Assay
Detection IgG antibodies against SARS COV-2 virus
Coated with SARS CoV-2 virus whole cell antigen
Absorbance 450 nm
Type of Specimen required Serum and Plasma
Assay Time 130 mins
Diagnostic Sensitivity 100%
Diagnostic Specificity 93%
Evaluations ICMR (NIV)

Size Chart

Ordering Information

Product Code Material Description Pack Size
CKMELI-01 ICMR-NIV Anti-SARS CoV-2 Human IgG ELISA
COVID KAVACH – MERILISA
96 Tests

Clinical Data

Enquire
Now